Lyu Tianchu, Wang Xifu, Su Zhanliang, Shangguan Junjie, Sun Chong, Figini Matteo, Wang Jian, Yaghmai Vahid, Larson Andrew C, Zhang Zhuoli
Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA Department of Radiology, Southwest Hospital, Third Military Medical University, Chongqing, China Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA Tianjin Key Laboratory of Cardiovascular Remodeling and Target Organ Injury, Pingjin Hospital Heart Center, Tianjin, China.
Medicine (Baltimore). 2017 Apr;96(17):e6386. doi: 10.1097/MD.0000000000006386.
Liver cancer makes up a huge percentage of cancer mortality worldwide. Irreversible electroporation (IRE) is a relatively new minimally invasive nonthermal ablation technique for tumors that applies short pulses of high frequency electrical energy to irreversibly destabilize cell membrane to induce tumor cell apoptosis.
This review aims to investigate the studies regarding the use of IRE treatment in liver tumors and metastases to liver. We searched PubMed for all of IRE relevant English language articles published up to September 2016. They included clinical trials, experimental studies, observational studies, and reviews. This review manuscript is nothing with ethics issues and ethical approval is not provided.
In recent years, increasingly more studies in both preclinical and clinical settings have been conducted to examine the safety and efficacy of this new technique, shedding light on the crucial advantages and disadvantages that IRE possesses. Unlike the current leading thermal ablation techniques, such as radiofrequency ablation (RFA), microwave ablation (MWA), and cryoablation, IRE requires shorter ablation time without damaging adjacent important vital structures.
Although IRE has successfully claimed its valuable status in the field of hepatic cancer treatment both preclinical and clinical settings. In order to systemically test and establish its safety and efficacy for clinical applications, more studies still need to be conducted.
肝癌在全球癌症死亡率中占比巨大。不可逆电穿孔(IRE)是一种相对较新的微创非热消融技术,用于肿瘤治疗,它通过施加高频电脉冲使细胞膜不可逆地不稳定,从而诱导肿瘤细胞凋亡。
本综述旨在研究IRE治疗肝肿瘤及肝转移瘤的相关研究。我们在PubMed上搜索了截至2016年9月发表的所有与IRE相关的英文文章。这些文章包括临床试验、实验研究、观察性研究和综述。本综述稿件不存在伦理问题,也未提供伦理批准。
近年来,越来越多的临床前和临床研究对这项新技术的安全性和有效性进行了检验,揭示了IRE的关键优缺点。与目前领先的热消融技术,如射频消融(RFA)、微波消融(MWA)和冷冻消融不同,IRE所需的消融时间更短,且不会损伤邻近的重要生命结构。
尽管IRE在临床前和临床环境中的肝癌治疗领域已成功确立了其宝贵地位。但为了系统地测试并确立其临床应用的安全性和有效性,仍需开展更多研究。